Featured Research

from universities, journals, and other organizations

Complementary Therapy For Infertile Women May Reduce Chances Of Pregnancy

Date:
July 5, 2007
Source:
European Society for Human Reproduction and Embryology
Summary:
Complementary therapies in assisted reproduction may diminish the effectiveness of medical treatment for infertility in women, a scientist will tell the 23rd Annual Conference of the European Society of Human Reproduction and Embryology in Lyon, France, Wednesday, July 4.

Complementary therapies in assisted reproduction may diminish the effectiveness of medical treatment for infertility in women, a scientist will tell the 23rd annual conference of the European Society of Human Reproduction and Embryology in Lyon, France, (Wednesday 4 July). Dr. Jacky Boivin, from the School of Psychology, Cardiff University, Wales, UK, will say that her research had also shown that women who used complementary therapies were more negatively affected by their fertility problems than non-users, and that this could account for the fact that they were willing to use complementary therapies that were not proven to improve fertility.

Many women use complementary or alternative therapies (CATs) to resolve fertility problems, even though there is little evidence that they are effective. However, it is not clear whether people use these to reduce stress or to increase their chances of getting pregnant. So Dr. Boivin and a colleague from the University of Copenhagen, Dr. Lone Schmidt, set out to study why women made these choices, in the hope of being able to better inform them both of their effectiveness and of other options for achieving pregnancy and reducing the stress of infertility.

They examined the psychosocial and medical profiles of 818 Danish women at the start of their IVF treatment, and then looked at which women went on to use complementary therapy in the subsequent 12 months. The study was the first large scale prospective evaluation of CAT use in an infertile population.

"We found that women who went on to use complementary therapies -- for example reflexology and nutritional supplements -- during their treatments were more distressed and emotionally affected by their fertility problems than non-users", says Dr. Boivin. "This difference in stress may mean that women used CATs for stress reduction, and if this were the case it would be important for future research to establish whether CATs achieve this goal more effectively than conventional psychological therapies."

So far, research shows that psychological therapies are more effective in achieving stress reduction. "But women may be reluctant to ask for this because of the stigma attached, or perhaps simply because they are not aware of the research", she says "We hope that our study will provide a good basis for women to make a decision on whether or not to use CATs as compared with other available options. We are currently developing brief coping interventions that may be more appealing to people who do not want to use conventional one or one or group counselling."

The study also found that women who used CAT had a 20% lower pregnancy success rate over the 12-month treatment period. Our findings do not allow us to make a direct causal link between CAT use and pregnancy rate", says Dr. Boivin. "It may be that complementary therapies diminish the effectiveness of medical interventions, as has been shown in previous research. Or it may simply be that persistent treatment failure encourages women to seek out CATs because they are more willing to try anything to get pregnant."

The next step for the researchers is to study the same group over a five year period and see how many become pregnant in the longer term. "It is important to do this because we are concerned that, with persistent treatment failure, women might become more and more susceptible to deceptive advertising about ineffective CATs or other unproven treatments", says Dr. Boivin.


Story Source:

The above story is based on materials provided by European Society for Human Reproduction and Embryology. Note: Materials may be edited for content and length.


Cite This Page:

European Society for Human Reproduction and Embryology. "Complementary Therapy For Infertile Women May Reduce Chances Of Pregnancy." ScienceDaily. ScienceDaily, 5 July 2007. <www.sciencedaily.com/releases/2007/07/070704144735.htm>.
European Society for Human Reproduction and Embryology. (2007, July 5). Complementary Therapy For Infertile Women May Reduce Chances Of Pregnancy. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2007/07/070704144735.htm
European Society for Human Reproduction and Embryology. "Complementary Therapy For Infertile Women May Reduce Chances Of Pregnancy." ScienceDaily. www.sciencedaily.com/releases/2007/07/070704144735.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins